Page 150 - 南京医科大学自然版
P. 150

第45卷第2期
               ·290 ·                            南 京    医 科 大 学 学         报                        2025年2月


                   microenvironment :new findings and future perspec⁃  anisms of metabolic reprogramming of tumor microenvi⁃
                   tives[J]. Mol Cancer,2021,20(1):131               ronment for immunotherapy in gastric cancer[J]. Cell
             [14]LI Y M,HU X D,LIN R C,et al. Single⁃cell landscape re⁃  Death Dis,2022,13(4):378
                   veals active cell subtypes and their interaction in the tu⁃  [26]JANJIGIAN Y Y,SHITARA K,MOEHLER M,et al. First
                   mor microenvironment of gastric cancer[J]. Theranostics,  ⁃line nivolumab plus chemotherapy versus chemotherapy
                   2022,12(8):3818-3833                              alone for advanced gastric,gastro⁃oesophageal junction,
             [15]LI X C,SUN Z,PENG G X,et al. Single⁃cell RNA se⁃    and oesophageal adenocarcinoma(CheckMate 649):a
                   quencing reveals a pro⁃invasive cancer⁃associated fibro⁃  randomised,open⁃label,phase 3 trial[J]. Lancet,2021,
                   blast subgroup associated with poor clinical outcomes in  398(10294):27-40
                   patients with gastric cancer[J]. Theranostics,2022,12  [27]FAN Y B,LI Y,YAO X D,et al. Epithelial SOX9 drives
                  (2):620-638                                        progressionandmetastasesofgastricadenocarcinomabypro⁃
             [16]LIU Y D,LI C F,LU Y P,et al. Tumor microenvironment⁃  moting immunosuppressive tumour microenvironment[J].
                   mediated immune tolerance in development and treat⁃  Gut,2023,72(4):624-637
                   ment of gastric cancer[J]. Front Immunol,2022,13:  [28]PARK S,KARALIS J D,HONG C J,et al. ACTA2 expres⁃
                   1016817                                           sion predicts survival and is associated with response to
             [17]WANG B,ZHANG Y Y,QING T,et al. Comprehensive        immune checkpoint inhibitors in gastric cancer[J]. Clin
                   analysis of metastatic gastric cancer tumour cells using  Cancer Res,2023,29(6):1077-1085
                   single⁃cell RNA⁃seq[J]. Sci Rep,2021,11(1):1141  [29]ZHANG P R,GU Y,WANG J T,et al. Complement recep⁃
             [18]HUANG X Z,PANG M J,LI J Y,et al. Single⁃cell se⁃    tor C5aR1 blockade reprograms tumor⁃associated macro⁃
                   quencing of ascites fluid illustrates heterogeneity and ther⁃  phages and synergizes with anti⁃PD⁃1 therapy in gastric
                   apy ⁃ induced evolution during gastric cancer peritoneal  cancer[J]. Int J Cancer,2023,153(1):224-237
                   metastasis[J]. Nat Commun,2023,14(1):822     [30]YANG L,YING X J,LIU S,et al. Gastric cancer:epidemi⁃
             [19]ZHANG J Z,WANG H,TIAN Y,et al. Discovery of a nov⁃  ology,risk factors and prevention strategies[J]. Chin J
                   el lipid metabolism⁃related gene signature to predict out⁃  Cancer Res,2020,32(6):695-704
                   comes and the tumor immune microenvironment in gastric  [31]DENG G H,ZHANG X,CHEN Y L,et al. Single⁃cell tran⁃
                   cancer by integrated analysis of single⁃cell and bulk RNA  scriptome sequencing reveals heterogeneity of gastric can⁃
                   sequencing[J]. Lipids Health Dis,2023,22(1):212   cer:progress and prospects[J]. Front Oncol,2023,13:
             [20]HU J W,YANG Y P,MA Y C,et al. Survival benefits     1074268
                   from neoadjuvant treatment in gastric cancer:a systematic  [32]SUN J R,KONG C F,YE Y X,et al. Integrated analysis of
                   review and meta⁃analysis[J]. Syst Rev,2022,11(1):  single⁃cell and bulk RNA⁃sequencing reveals a novel sig⁃
                   136                                               nature based on NK cell marker genes to predict progno⁃
             [21]MARIN J J G,PEREZ⁃SILVA L,MACIAS R I R,et al.       sis and immunotherapy response in gastric cancer[J]. Sci
                   Molecular bases of mechanisms accounting for drug resis⁃  Rep,2024,14(1):7648
                   tance in gastric adenocarcinoma[J]. Cancers,2020,12  [33]LI Z P,CHEN H,CHEN Z Q,et al. Bioinformatics analy⁃
                  (8):2116                                           sis reveals prognostic significance of the macrophage
             [22]YIN H H,SUN L L,YUAN Y,et al. PPIC⁃labeled CAFs:    marker gene signature in gastric adenocarcinoma[J].
                   key players in neoadjuvant chemotherapy resistance for  Front Biosci,2024,29(5):172
                   gastric cancer[J]. Transl Oncol,2024,48:102080  [34]CAI X,YANG J R,GUO Y S,et al. Re⁃analysis of single
             [23]LU Y F,JIN Z J,HOU J Y,et al. Calponin 1 increases  cell and spatial transcriptomics data reveals B cell land⁃
                   cancer⁃associated fibroblasts⁃mediated matrix stiffness to  scape in gastric cancer microenvironment and its poten⁃
                   promote chemoresistance in gastric cancer[J]. Matrix Bi⁃  tial crosstalk with tumor cells for clinical prognosis[J]. J
                   ol,2023,115:1-15                                  Transl Med,2024,22(1):807
             [24]JIA X Y,LI Z T,ZHOU R Y,et al. Single cell and bulk  [35]WANG S,SUN S T,ZHANG X Y,et al. The evolution of
                   RNA sequencing identifies tumor microenvironment sub⁃  single⁃cell RNA sequencing technology and application:
                                                +
                   types and chemoresistance⁃related IGF1 cancer⁃associat⁃  progress and perspectives[J]. Int J Mol Sci,2023,24(3):
                   ed fibroblast in gastric cancer[J]. Biochim Biophys Acta  2943
                   Mol Basis Dis,2024,1870(4):167123                                      [收稿日期] 2024-08-27
             [25]ZHAO L,LIU Y Y,ZHANG S M,et al. Impacts and mech⁃                            (本文编辑:陈汐敏)
   145   146   147   148   149   150   151   152   153   154   155